StockNews.com initiated coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Free Report) in a research report sent to investors on Thursday morning. The firm issued a sell rating on the biopharmaceutical company’s stock.
Onconova Therapeutics Price Performance
Shares of ONTX opened at $1.00 on Thursday. The firm has a 50 day simple moving average of $0.85 and a two-hundred day simple moving average of $0.74. Onconova Therapeutics has a one year low of $0.55 and a one year high of $1.45. The company has a market cap of $20.90 million, a P/E ratio of -1.09 and a beta of 1.38.
About Onconova Therapeutics
See Also
- Five stocks we like better than Onconova Therapeutics
- The 3 Best Retail Stocks to Shop for in August
- Brinker International Heats Up on Spicy Earnings Beat and Raise
- What is Insider Trading? What You Can Learn from Insider Trading
- Eli Lilly Gains on the GLP-1 Weight Loss Phenomenon
- 3 Healthcare Dividend Stocks to Buy
- Pfizer Finds a Foothold After a Solid Q1 2024 Earnings Report
Receive News & Ratings for Onconova Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Onconova Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.